TALBOT MEDICAL CENTRE
STANLEY STREET, SOUTH SHIELDS
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 26 | 27 | 96.3% | |
| HF 4 | 2011 | 26 | 28 | 92.9% | |
| HF 4 | 2012 | 28 | 31 | 90.3% | |
| HF 4 | 2013 | 28 | 30 | 93.3% | |
| HF004 | 2014 | 26 | 29 | 89.7% | |
| HF004 | 2015 | 33 | 34 | 97.1% | |
| HF004 | 2016 | 47 | 48 | 97.9% | |
| HF004 | 2017 | 59 | 59 | 100.0% | |
| HF004 | 2018 | 62 | 63 | 98.4% | |
| HF004 | 2019 | 65 | 67 | 97.0% | |
| HF004 | 2020 | 67 | 74 | 90.5% | |
| HF006 | 2021 | 79 | 89 | 88.8% | |
| HF006 | 2022 | 70 | 74 | 94.6% | |
| HF006 | 2023 | 75 | 76 | 98.7% |
